Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jolly

Showing results (201-210 of 233) with videos related to

Pageof 24
Sort By:
Molecular Psychiatry|September 27, 2017
A Upf3b-mutant mouse model with behavioral and neurogenesis defectsL Huang, E Y Shum, S H Jones, et al.
Regulatory Toxicology and Pharmacology : RTP|February 7, 2018
Potential impurities in drug substances: Compound-specific toxicology limits for 20 synthetic reagents and by-products, and a class-specific toxicology limit for alkyl bromidesJ P Bercu, S M Galloway, P Parris, et al.
Clinical Breast Cancer|September 24, 2024
Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation TherapyRyan T Morse, Nathan W Bean, Jacob Hall, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 4, 2005
Data-driven analysis approach for biomarker discovery using molecular-profiling technologiesT Wei, B Liao, B L Ackermann, et al.
JNCI Cancer Spectrum|January 7, 2021
Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, <i>p16</i>Shlomit S Shachar, Allison M Deal, Katherine E Reeder-Hayes, et al.
Journal of the National Cancer Institute|April 1, 2014
Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancerHanna K Sanoff, Allison M Deal, Janakiraman Krishnamurthy, et al.
American Journal of Human Genetics|September 25, 2012
A noncoding, regulatory mutation implicates HCFC1 in nonsyndromic intellectual disabilityLingli Huang, Lachlan A Jolly, Saffron Willis-Owen, et al.
Environmental and Molecular Mutagenesis|July 24, 2019
In Vivo Mutagenicity Testing of Arylboronic Acids and EstersMelisa J Masuda-Herrera, Krista L Dobo, Michelle O Kenyon, et al.
Breast Cancer Research and Treatment|November 5, 2021
Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancerK A Nyrop, E M Damone, A M Deal, et al.
Cancer|November 20, 2020
Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancerKirsten A Nyrop, Allison M Deal, Yi Tang Chen, et al.
Pageof 24

Showing results (201-210 of 233) with videos related to

Sort By:
Pageof 24
Molecular Psychiatry|September 27, 2017
A Upf3b-mutant mouse model with behavioral and neurogenesis defectsL Huang, E Y Shum, S H Jones, et al.
Regulatory Toxicology and Pharmacology : RTP|February 7, 2018
Potential impurities in drug substances: Compound-specific toxicology limits for 20 synthetic reagents and by-products, and a class-specific toxicology limit for alkyl bromidesJ P Bercu, S M Galloway, P Parris, et al.
Clinical Breast Cancer|September 24, 2024
Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation TherapyRyan T Morse, Nathan W Bean, Jacob Hall, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 4, 2005
Data-driven analysis approach for biomarker discovery using molecular-profiling technologiesT Wei, B Liao, B L Ackermann, et al.
JNCI Cancer Spectrum|January 7, 2021
Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, <i>p16</i>Shlomit S Shachar, Allison M Deal, Katherine E Reeder-Hayes, et al.
Journal of the National Cancer Institute|April 1, 2014
Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancerHanna K Sanoff, Allison M Deal, Janakiraman Krishnamurthy, et al.
American Journal of Human Genetics|September 25, 2012
A noncoding, regulatory mutation implicates HCFC1 in nonsyndromic intellectual disabilityLingli Huang, Lachlan A Jolly, Saffron Willis-Owen, et al.
Environmental and Molecular Mutagenesis|July 24, 2019
In Vivo Mutagenicity Testing of Arylboronic Acids and EstersMelisa J Masuda-Herrera, Krista L Dobo, Michelle O Kenyon, et al.
Breast Cancer Research and Treatment|November 5, 2021
Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancerK A Nyrop, E M Damone, A M Deal, et al.
Cancer|November 20, 2020
Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancerKirsten A Nyrop, Allison M Deal, Yi Tang Chen, et al.
Pageof 24